YTHDF1 and neoplasm: METTL3 is overexpressed in GC tissues, enhancing FNTA translation through YTHDF1-dependent m6A modifications, maintaining KRAS membrane localization and continuously activating the MEK/ERK pathway, driving tumor progression and metastasis.